# Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease

> **NCT04324138** · EARLY_PHASE1 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 78 (estimated)

## Conditions studied

- Nonerosive Reflux Disease

## Interventions

- **DRUG:** Jianpi Qinghua granules
- **DRUG:** Jianpi Qinghua placebo granules

## Key facts

- **NCT ID:** NCT04324138
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-15
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2021-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04324138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04324138, "Efficacy and Safety of Jianpi Qinghua Granules in Patients With Nonerosive Reflux Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04324138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*